© The Financial Times Ltd 2014 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
|Market cap||462.73m USD|
|EPS (TTM)||-0.9252 USD|
Jul 31 2014 21:05 BSTInitiation of Multiple Ascending Dose Phase 1 Study of PRX002 in Patients With Parkinson's Disease
Jun 23 2014 21:20 BSTProthena Announces Proposed Offering of Ordinary Shares
May 27 2014 21:05 BSTProthena to Present at the Jefferies 2014 Global Healthcare Conference in New York
May 05 2014 21:05 BSTProthena Reports First Quarter 2014 Financial Results and Provides R&D Updates
May 01 2014 21:05 BSTProthena to Host Webcast and Conference Call to Discuss Interim Phase 1 Data of Ongoing NEOD001 Study in Patients With AL Amyloidosis on May 2